Startup profile · funding coverage
EGIDE funding, valuation and investors
Affordable electrically propelled interceptors and Mystique C-UAS platform for drone defense.
Keep track of EGIDE
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
€8M · March 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Ris-Orangis (Paris), France
Investors in latest funding
Lead: Expeditions , Eurazeo , Heartcore Capital
Other: Galion.exe , Kima Ventures
Overview
EGIDE is a French defense-technology startup building affordable, scalable counter-UAS systems for air, ground, and maritime missions. Its hardware includes electrically propelled interceptors; its Mystique platform provides hardware-agnostic detection, AI-driven tracking, and layered interception via distributed sensors. Founded in 2025 in Ris-Orangis (Paris region) by former MBDA engineers Simon Calonne (CEO, GNC) and Florian Audigier (CTO, warhead design), EGIDE raised €8M seed in March 2026 co-led by Expeditions, Eurazeo, and Heartcore Capital, with Galion.exe and Kima Ventures participating.
Why EGIDE is interesting
EGIDE's €8M seed in March 2026 — led by Eurazeo and Heartcore — backs ex-MBDA engineers building mass-producible interceptors for drone swarms, a procurement gap NATO allies are now funding at seed stage.
Product & use cases
EGIDE builds low-cost interceptors and the Mystique software platform — combining distributed sensors, AI detection, and layered kill chains to counter mass-produced drones and strike munitions at scale.
- European ministries procuring sovereign counter-drone systems for battlefield and base defense
- Critical infrastructure protection (airports, stadiums, energy sites) against drone incursions
- NATO-aligned stockpile rebuilding after Ukraine and Middle East conflicts exposed interceptor shortages
Key facts
- Seed (Mar 2026): €8M co-led by Expeditions, Eurazeo, and Heartcore Capital (company press release)
- Founders are ex-MBDA aerospace and pyrotechnics engineers
- Products: electrically propelled interceptors + Mystique AI detection/interception platform
- Targets air, maritime, and ground C-UAS missions for European defense customers
- Small team (~6–9 employees) recruiting across propulsion, aerodynamics, and software
Funding history (newest first)
Seed
2026-03 €8M- Expeditions (lead)
- Eurazeo (lead)
- Heartcore Capital (lead)
- Galion.exe (participant)
- Kima Ventures (participant)
Competitive landscape
Edge: EGIDE designs for mass production and modularity from day one — shifting from scarce, high-cost munitions to networked interceptors priced for swarm threats, with founders who built guidance and warhead systems at MBDA.
C-UAS is shifting from exotic airport gear to battlefield necessity as cheap drones reshape conflict economics. EGIDE competes on cost-per-intercept and European sovereignty; U.S. players like Anduril lead on scale, while RF-jamming alternatives avoid kinetic costs but face regulatory and effectiveness tradeoffs.
-
Anduril (Pulsar / Sentry) direct
U.S. C-UAS and autonomous defense platform with larger funding and DoD traction.
-
Dedrone (Axon) adjacent
Detection-first C-UAS; acquired by Axon; less focused on kinetic interceptors.
-
D-Fend Solutions direct
RF-based drone takeover and mitigation; different kill mechanism vs kinetic interceptors.
-
Thales / MBDA incumbent
Legacy missile and defense primes; slower iteration but established procurement channels EGIDE's founders know from inside.
Notable stories
- Founders Simon Calonne and Florian Audigier left MBDA — Europe's leading missile maker — to build interceptors designed for drone swarms, not single high-value targets (Tech.eu, March 2026).
- EGIDE announced its seed round during the Paris Defence and Strategy Forum week, as European policymakers prioritized rebuilding interceptor stockpiles (Expeditions fund release).
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover EGIDE's financing or category context.
FAQs about EGIDE
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.